SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015019
Filing Date
2018-10-31
Accepted
2018-10-31 06:16:25
Documents
42
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 256793
2 ex31-1.htm EX-31.1 12524
3 ex31-2.htm EX-31.2 12543
4 ex32-1.htm EX-32.1 6079
5 ex32-2.htm EX-32.2 6056
  Complete submission text file 0001493152-18-015019.txt   1453608

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE capd-20180930.xml EX-101.INS 153538
7 XBRL SCHEMA FILE capd-20180930.xsd EX-101.SCH 18349
8 XBRL CALCULATION FILE capd-20180930_cal.xml EX-101.CAL 30685
9 XBRL DEFINITION FILE capd-20180930_def.xml EX-101.DEF 57852
10 XBRL LABEL FILE capd-20180930_lab.xml EX-101.LAB 131205
11 XBRL PRESENTATION FILE capd-20180930_pre.xml EX-101.PRE 108305
Mailing Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916
Business Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916 972-3-6130421
CANNAPOWDER, INC. (Filer) CIK: 0001086082 (see all company filings)

IRS No.: 870626333 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26027 | Film No.: 181148618
SIC: 2834 Pharmaceutical Preparations